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     Burn wounds are a significant medical challenge today. Current treat-
ment includes the use of skin grafts or wound healing scaffolds to protect 
the wound and promote healing. However, pre-existing conditions and fac-
tors such as smoking can compromise normal healing thru decreased growth 
factor production, prolonged inflammation, tissue hypoxia, reduced cellular 
migration and ECM deposition, and impaired revascularization, making the 
wound more susceptible to infection. 
     Adult pluripotent cells have been proposed as a therapy for multiple dis-
orders because they have been shown to decrease inflammation and pro-
mote host tissue preservation and angiogenesis. Adipose-derived stromal 
cells (ASC) are a population of mesenchymal, pluripotent cells derived from 
adipose tissue. Compared to bone marrow derived MSC, ASC can be easily 
obtained thru minimally invasive procedures. It has been shown in previous 
studies that ASC improved wound closure in normal and diabetic mice and 
stimulated proliferation of human dermal fibroblasts, increasing the epitheli-
alization of cutaneous wounds.  
     The next challenge is to find a clinically relevant cell-delivery method. 
In light of this, we propose the use of current clinical wound healing scaf-
folds as a delivery vehicle for ASC in combination with endothelial cell (EC) 
and keratinocytes. We hypothesize that that ASC will promote keratinocyte 
and EC survival (both are used clinically), thus promoting epithelialization 
and neovascularization of graft. The use of ASC, EPC and keratinocytes in 
combination with wound healing scaffolds currently used by physicians, such 
as Integra is a novel combination and will provide a faster transition to clinic 
if it is found to be efficacious. 
     Our lab has shown that ASC promote survival of EC on Integra and sup-
port the formation of vascular-like cord structures. Factors secreted by ASC 
promote keratinocytes ingrowth in a wound closure assay. Keratinocytes also 
showed increased survival when cultured with ASC.  
